United States· US:71610-663_31e57817-b8c3-8178-e063-6294a90a0149

Omeprazole

A omeprazole product containing omeprazole, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 19 of our 19 countries.

ATC A02BC01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOmeprazoleATCA02BC01REGISTER NO.US:71610-663_31e57817…PACKS LISTED20CHECKEDSeptember 27, 2026

Where it is registered

Omeprazole is registered in 19 of 19 countries.

Countries holding a registration under ATC A02BC01 (omeprazole), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 11 of them publish a price we can compare per daily dose

Omeprazole · ATC A02BC01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of omeprazole costs, country by country.

Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.10 in Spain to $1.17 in Switzerland — a ×12 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Omeprazole · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.17
  • IT Italy$0.46
  • ES Spain$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
OMEPRAZOLE
Manufacturer
Aphena Pharma Solutions - Tennessee, LLC
Country
United States (US)
ATC code
A02BC01
ATC class
Omeprazole
Defined daily dose
20 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 20

  • ndc11
    71610-663-30
  • ndc11
    71610-663-51
  • ndc11
    7161066300
    1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-00)
  • ndc11
    7161066330
    30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-30)
  • ndc11
    7161066351
    4800 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-51)
  • ndc11
    7161066353
    60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-53)
  • ndc11
    7161066356
    9200 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-56)
  • ndc11
    7161066360
    90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-60)
  • ndc11
    7161066370
    120 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-70)
  • ndc11
    7161066380
    180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-80)
  • ndc11
    7161066387
    2400 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-87)
  • ndc11
    7161066394
    360 CAPSULE, DELAYED RELEASE in 1 BOTTLE (71610-663-94)
  • ndc11
    71610-663-00
  • ndc11
    71610-663-53
  • ndc11
    71610-663-56
  • ndc11
    71610-663-60
  • ndc11
    71610-663-70
  • ndc11
    71610-663-80
  • ndc11
    71610-663-87
  • ndc11
    71610-663-94

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

802 interactions on record for omeprazole.

Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Omeprazole · interactions on record

802 records

  • 25 severe
  • 136 moderate
  • 62 minor
  • 568 info

Most severe, free to view

  • ClopidogrelB01AC04severe
  • CilostazolB01AC23severe
  • NelfinavirJ05AE04severe
  • AtazanavirJ05AE08severe

11 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Omeprazole in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All omeprazole products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Losec, Omec
  • Belgium · Acidcare, Lappoxo
  • Bulgaria · Probitor, Биопразол
  • Cyprus · Ezipol, Medoprazole
  • Czechia · Helicid, Helicid Neo
  • Germany · Antra Mups, Gastrobin Protect
  • Denmark · Lappoxo, Losec
  • Estonia · Gasec Gastrocaps, Lappoxo
  • Spain · Arapride, Aulcer
  • Finland · Losec, Losec Mups
  • France · Arpemix, Mopral
  • United Kingdom (Northern Ireland) · Aylome, Boots One-A-Day Acid Reflux Relief
  • Greece · Alevior, Assoprol
  • Croatia · Lappoxo, Ortalox
  • Hungary · Helant, Lappoxo
  • Ireland · Appizped, Losec Control
  • Iceland · Omeprazol Actavis, Omeprazol Medical Valley
  • Italy · Anadir, Antra
  • Lithuania · Gasec, Lappoxolo
  • Luxembourg · Losec-Mups, Omeprazol Nt Ratiopharm
  • Latvia · Gasec Gastrocaps, Lappoxo
  • Malta · Losec Control, Losec Mups
  • Netherlands · Appizmit, Kruidvat Maagzuurremmer
  • Norway · Lappoxo, Losec Mups
  • Poland · Agastin 20 Mg, Apteo Med
  • Portugal · Albosan, Gasec
  • Romania · Helant, Lappoxo
  • Sweden · Appizmit, Helicid
  • Slovenia · Lappoxo, Ortanol
  • Slovakia · Helicid, Helicid Neo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7af75c2-cfae-424e-bcec-f8b723aecdc8
GET /v1/drugs/f7af75c2-cfae-424e-bcec-f8b723aecdc8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "20",
  "substance": "OMEPRAZOLE",
  "productndc": "71610-663",
  "dosage_form": "CAPSULE, DELAYED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA212977",
  "marketing_category": "ANDA"
}

See everything about omeprazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.